Effect of Surgical Approach on Postoperative Bleeding in Patien Arthroplasty

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

50 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-02-13

Study Completion Date

2025-09-30

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The study is, in accordance with current legislation, definable as monocentric Prospective Observational.

The primary outcome will be blood loss calculated on the basis of hemoglobin (Hb) on the third postoperative day.

adult patients who will undergo surgery of hip arthroplasty.

Patients will undergo:

Preoperative T0: clinical visit/medical history, completion of the VAS questionnaire, Blood sampling to assess hemoglobin values Operative T1: hip arthroplasty surgery using one of the surgical approaches routinely used within our Institute T2 - Postoperative at 1 day from T1: VAS questionnaire, evaluation of any Adverse events T3 - Postoperative at 3 days from T1: blood loss based on the values of hemoglobin (Hb), assessment of any adverse events, and VAS questionnaire T4- Post operative at 45 days +/- 10 days from T1: evaluation of any events adverse, follow-up visit.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Assessing the Perioperative Outcomes of Minimally Invasive Posterior Approach Versus Direct Anterior Approach Total Hip Arthroplasty.

NCT06659198

Total Hip Replacement Surgery

COMPLETED NA

An Algorithm for Predicting Blood Loss and Transfusion Risk in Fast Track Total Hip Arthroplasty

NCT02750852

Total Hip Replacement Blood Loss

UNKNOWN

An Evaluation of Clotting Factor Activity Before and After Total Hip Arthroplasty

NCT04372173

Arthroplasty, Replacement Coagulation Factors

COMPLETED

Does Vessel-sparing Surgery in Anterior Approach Total Hip Arthroplasty Change Clinical Outcome?

NCT06308965

Tensor Fasciae Latae Syndrome Arthroplasty Complications

RECRUITING NA

Predictive Model for Postoperative Complications in Hemi-hip Arthroplasty

NCT03375268

Complication Risk Factor Elderly Patient +1 more

UNKNOWN

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The presence of bleeding and pain after prosthesis surgery Hip injuries can affect the patient's condition in the postoperative period increasing the length of hospital stay and slowing down the rehabilitation process.

It is hypothesized that there are differences in terms of postoperative bleeding, Postoperative pain and hospital stay time between different approaches surgical procedures in the treatment of hip osteoarthritis with arthroprosthesis. The adoption of a Surgical approach that can reduce bleeding and pain could reduce the length of hospital stay in patients undergoing hip arthroplasty.

The primary outcome will be blood loss calculated on the basis of hemoglobin (Hb) on the third postoperative day.

Secondary objectives are postoperative pain assessment with questionnaire VAS and length of hospital stay according to surgical approach used (anterior Vs. posterolateral route). Also evaluate Any adverse events.

Adult patients who will undergo surgery of hip arthroplasty.

The inclusion criteria are:

* adult patients with coxarthrosis who are candidates for surgery hip arthroplasty
* Signing of the Informed Consent and consent to collaborate in all study procedures.

The exclusion criteria are:

* Minors
* Pregnant women (self-declaration)
* patients with BMI ≥ 30
* Non-acceptance of informed consent
* Patients with prior unilateral hip reconstructive surgery or Contralateral

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Hip Arthropathy

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Anterior hip arthroplasty

Intervention Type PROCEDURE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* adult patients with coxarthrosis who are candidates for surgery hip arthroplasty
* Signing of the Informed Consent and consent to collaborate in all study procedures.

Exclusion Criteria

* Minors
* Pregnant women (self-declaration)
* patients with BMI ≥ 30
* Non-acceptance of informed consent
* Patients with prior unilateral hip reconstructive surgery or Contralateral

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No